Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 2

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 79Observational 6

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 5Liver Neoplasms 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Observational × cabozantinib × Clear all
NCT04416646 2026-04-13

ZEBRA

Istituto Oncologico Veneto IRCCS

Completed
100 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05100082 2025-12-30

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Takeda

Completed
263 enrolled
Gastrointestinal

Liver Neoplasms

NCT04804813 2025-04-11

Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

Takeda

Completed
388 enrolled 20 charts
Genitourinary

Carcinoma, Renal Cell

NCT04510688 2022-10-26

SRWEC

Spanish Oncology Genito-Urinary Group

Completed
275 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04353765 2021-11-17

US NIS Cabo

Ipsen

Completed
247 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04637204 2021-02-01

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Ipsen

Completed
1,540 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡